Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:angiogenesis inhibitor
go back to main search page
Accession:CHEBI:48422 term browser browse the term
Definition:An agent and endogenous substances that antagonize or inhibit the development of new blood vessels.
Synonyms:related_synonym: angiogenesis antagonist;   angiostatic agents;   anti-angiogenic agent
 alt_id: CHEBI:67170
 xref: Wikipedia:Angiogenesis_inhibitor


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19734
    role 19680
      application 19336
        pharmaceutical 19211
          drug 19211
            angiogenesis inhibitor 8274
              (-)-antofine 2
              (-)-matairesinol + 0
              (1R,2S,3S,4S)-4-formyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexyl (2E)-3-(4-methoxyphenyl)acrylate 0
              (1S,2S,3S)-3-methoxy-2-[(2E)-6-methylhept-2-en-2-yl]-4-oxocyclohexanecarbaldehyde + 0
              (2S,3S,4S)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]-4-(trifluoroacetyl)cyclohexanone 0
              (2S,3S,4S)-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone 0
              (2S,3S,4S)-4-(hydroxymethyl)-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone 0
              (2S,3S,4S)-4-acetyl-2-methoxy-3-[(2E)-6-methylhept-2-en-2-yl]cyclohexanone 0
              (4Z,7Z,10Z,12E,14S,16Z,19Z,21R)-dihydroxydocosahexaenoic acid 0
              3PO 0
              JQ1 0
              N-(5-\{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl\}-1,3-thiazol-2-yl)piperidine-4-carboxamide 0
              O-(chloroacetylcarbamoyl)fumagillol 10
              SB220025 0
              SH-11037 0
              SU4312 0
              ageladine A 4
              amentoflavone + 26
              cafestol 20
              capsiate 7
              crenolanib 0
              disulfiram 567
              epoxytwinol A 0
              fumagillin + 5
              kahweol 31
              lenalidomide 29
              leucosesterlactone 0
              leucosesterterpenone 0
              linifanib 0
              luminespib 0
              lupulone 0
              luteolin + 148
              meso-tetrakis(N-methyl-4-pyridyl)porphine tetrakis(p-toluenesulfonate) 0
              meso-tetrakis(N-methyl-4-pyridyl)porphine(4+) + 1
              nintedanib 1
              nintedanib esylate 0
              oridonin 26
              pomalidomide 44
              quininib 0
              quininib hydrochloride 0
              rifampicin + 368
              sorafenib + 153
              sunitinib + 5774
              tamoxifen + 3172
              tamoxifen citrate 0
              thalidomide + 437
              toluquinol 0
              vatalanib + 2
              vatalanib succinate 0
              voacangine 0
              wogonin + 43
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.